Integrated Molecular and Immunophenotypic Analysis of NK Cells in Anti-Pd-1 Treated Metastatic Melanoma Patients

OncoImmunology - United States
doi 10.1080/2162402x.2018.1537581
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Comprehensive Molecular and Clinical Characterization of Asian Melanoma Patients Treated With Anti-Pd-1 Antibody

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

777 Enhanced Recovery of PD-1 Expression on the Cell Surface of PD-1 Negative T Cells in Nivolumab-Treated Advanced Melanoma Patients

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

CTLA4 Methylation Predicts Response to Anti–PD-1 and Anti–CTLA-4 Immunotherapy in Melanoma Patients

JCI insight
Medicine
2018English

823 Biomarker Approaches for Anti-Pd-1 in Melanoma: A Meta-Analysis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’

British Journal of Cancer
Cancer ResearchOncology
2017English

Cutaneous Adverse Events (AEs) of Anti-Programmed Cell Death (PD)-1 Therapy in Patients With Metastatic Melanoma: A Single-Institution Cohort

Journal of the American Academy of Dermatology
Dermatology
2016English

Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies

JAMA Oncology
Cancer ResearchOncology
2018English

Site‐specific Response Patterns, Pseudoprogression, and Acquired Resistance in Patients With Melanoma Treated With Ipilimumab Combined With Anti–PD‐1 Therapy

Cancer
Cancer ResearchOncology
2019English

Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma

New England Journal of Medicine
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy